BIOCYTOGEN-B 02315Hong Kong Stock Exchange

69.2001.14%( -0.800 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
BIOCYTOGEN-B (02315) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2022-09-01
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100005D27
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.62B43/112
Net Profit (Last FY)203.10M43/125
ROE (Last FY)7.96%33/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
沈月雷 Executive Director
倪健 Executive Director
刘弘康 Non-Executive Director
周可祥 Non-Executive Director
张蕾娣 Non-Executive Director
华风茂 Independent Non-Executive Director
喻长远 Independent Non-Executive Director
梁晓燕 Independent Non-Executive Director
李妍 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-02-12.

About this page

This page shows BIOCYTOGEN-B (02315) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.